Literature DB >> 2514138

Divalent hapten-induced intestinal anaphylaxis in the mouse: uptake and characterization of a bystander protein.

R E Kleinman1, P R Harmatz, R A Hatz, M Brown, P D Ariniello, W A Walker, K J Bloch.   

Abstract

We examined the mucosal barrier function during anaphylaxis induced by the hapten N,N'-di-2,4,dinitrophenyl-lysine (di-DNP-lysine) in BDF1 female mice immunized with dinitrophenylated Ascaris suum extract. Immunized mice were gavaged with 10 mg or 50 mg of ovalbumin (OVA) with or without N,N'-di-2,4,-DNP-lysine (di-DNP-lysine). Animals that received di-DNP-lysine underwent anaphylaxis and were observed to have significantly greater serum concentrations of immunoreactive OVA (iOVA) than control mice. The severity of anaphylaxis, which varied with the dose of di-DNP-lysine administered, influenced the uptake of OVA; greater amounts of iOVA were detected in serum of mice undergoing more severe anaphylaxis. On gel permeation of serum from both groups of mice, immunoreactive OVA was found to have a molecular size similar to native OVA. Di-DNP-lysine is a synthetic hapten that reliably induced anaphylaxis in sensitized animals challenged by gavage. Anaphylaxis resulted in the uptake into the circulation of greater quantities of an unrelated protein antigen present in the intestinal lumen. The protein antigen that was taken up into the circulation appeared to be intact and thus may have an influence on the development of the immune response, or lack thereof, to this bystander antigen.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514138      PMCID: PMC1385531     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  17 in total

1.  Enzyme-labeled antibodies: preparation and application for the localization of antigens.

Authors:  P K Nakane; G B Pierce
Journal:  J Histochem Cytochem       Date:  1966-12       Impact factor: 2.479

2.  Absorption of antigens after oral immunisation and the simultaneous induction of specific systemic tolerance.

Authors:  E T Swarbrick; C R Stokes; J F Soothill
Journal:  Gut       Date:  1979-02       Impact factor: 23.059

3.  Hypersensitivity to Ascaris antigens. I. Skin-sensitizing activity of serum fractions from guinea pigs sensitized to crude extracts.

Authors:  G Strejan; D H Campbell
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

4.  Intestinal uptake of macromolecules. VI. Uptake of protein antigen in vivo in normal rats and in rats infected with Nippostrongylus brasiliensis or subjected to mild systemic anaphylaxis.

Authors:  K J Bloch; D B Bloch; M Stearns; W A Walker
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

5.  Intestinal anaphylaxis in the rat as a model of food allergy.

Authors:  N E Byars; R W Ferraresi
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

6.  Passive transplacental immunization: influence on the detection of enteric antigen in the systemic circulation.

Authors:  R E Kleinman; P R Harmatz; L A Jacobson; J N Udall; K J Bloch; W A Walker
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

7.  Passage of ingested protein into the blood during gastrointestinal hypersensitivity reactions: experiments in the preruminant calf.

Authors:  P J Kilshaw; H Slade
Journal:  Clin Exp Immunol       Date:  1980-09       Impact factor: 4.330

8.  Immunological responses to fed protein antigens in mice. II. Oral tolerance for CMI is due to activation of cyclophosphamide-sensitive cells by gut-processed antigen.

Authors:  S Strobel; A M Mowat; H E Drummond; M G Pickering; A Ferguson
Journal:  Immunology       Date:  1983-07       Impact factor: 7.397

9.  The influence of intestinal processing on the immunogenicity and molecular size of absorbed, circulating ovalbumin in mice.

Authors:  M G Bruce; A Ferguson
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

10.  Effect of locally induced intestinal anaphylaxis on the uptake of a bystander antigen.

Authors:  K J Bloch; W A Walker
Journal:  J Allergy Clin Immunol       Date:  1981-04       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.